Ibrutinib ≥98%
Supplier: ADIPOGEN CORP MS
|
Danger
|
Synonyms:
(R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one, PCI-32765
Potent and highly selective Bruton's tyrosine kinase (BTK) inhibitor. Orally bioavailable and irreversible inhibitor of BTK (IC50 = 0.5 nM) with antineoplastic activity. Binds to and irreversibly inhibits BTK activity, preventing B cell activation and B cell-mediated signaling. This leads to an inhibition of the growth of malignant B cells that overexpress BTK. Shown to inhibit autophosphorylation of BTK (IC50 = 11nM), phosphorylation of PLCgamma (IC50 = 29nM), a substrate of BTK and phosphorylation of ERK (IC50 = 13nM).
Formula:
C₂₅H₂₄N₆O₂ MW: 440.5 g/mol Storage Temperature: Freezer |
MDL Number:
MFCD20261150 CAS Number: 936563-96-1 |
Specification Test Results
Purity |
|
Appearance/Color | White solid. |
Solubility | Soluble in DMSO. Slightly soluble in ethanol (1mg/ml). Insoluble in water. |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...